PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 2609971

[Studies on multiwavelength absorbance ratio difference spectrophotometry and its application].

B M Xu·T X Bi
View original source ↗Export metadata ↓

Abstract

This paper provides a new method to determine mixed component system by multiwavelength absorbance ratio difference spectrophotometry and summarized the basic principle and experimental technique of this method. This method was applied to assay the contents of two kinds of mixed component system of diphenhydramine hydrochloride and ephedrine hydrochloride, amidopyrine and caffeine without separation. The mean recoveries with coefficient of variation (%) was 101.0% (1.0%) for ephedrine hydrochloride; 94.86% (0.56%) for diphenhydramine hydrochloride; 100.3% (0.70%) for amidopyrine and 100.1% (0.75%) for caffeine. The results obtained are satisfactory both in recovery and in precision. It is a simple and rapid method to determine mixed component system.

Explore related subjects

AminopyrineCaffeineDiphenhydramineDrug CombinationsEphedrineSpectrophotometryEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B M Xu, T X Bi. 1989. [Studies on multiwavelength absorbance ratio difference spectrophotometry and its application].. https://pubmed.ncbi.nlm.nih.gov/2609971/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin.

The action of ghrelin on telemetrically recorded motor activity and the transmission of the effects of this neuropeptide on spontaneous and exploratory motor activity and some related endocrine and homeostatic parameters were investigated. Different doses (0.5-5 microg) of ghrelin administered intracerebroventricularly caused significant increases in both square crossing and rearing activity in the "open-field" apparatus, while only the dose of 5 microg evoked a significant increase in the spontaneous locomotor activity recorded by telemetry. Ghrelin also induced significant increases in corticosterone release and core temperature. To determine the transmission of these neuroendocrine actions, the rats were pretreated with different antagonists, such as a corticotropin-releasing hormone (CRH) antagonist (alpha-helical CRH(9-41)), the nitric oxide synthase inhibitor Nomega-nitro-L-arginine-methyl ester (L-NAME), haloperidol, cyproheptadine or the cyclooxygenase inhibitor noraminophenazone (NAP). The open-field and biotelemetric observations revealed that the motor responses were diminished by pretreatment with the CRH antagonist and haloperidol. In the case of HPA (hypothalamic pituitary adrenal) activation, only cyproheptadine pretreatment proved effective; haloperidol and L-NAME did not modify the corticosterone response. NAP had only a transient, while cyproheptadine elicited a more permanent impact on the hyperthermic response evoked by ghrelin; the other antagonists proved to be ineffective. The present data suggest that both CRH release and dopaminergic transmission may be involved in the ghrelin-evoked behavioral responses. On the other hand, ghrelin appears to have an impact on the HPA response via a serotonergic pathway and on the hyperthermic response via a cyclooxygenase and a serotonergic pathway.

Aminopyrine↗